University of East Anglia Featured PhD Programmes
Xi’an Jiaotong-Liverpool University Featured PhD Programmes
Lancaster University Featured PhD Programmes
"therapeutics"×
10 miles

therapeutics PhD Projects, Programs & Scholarships

We have 113 therapeutics PhD Projects, Programs & Scholarships

  • "therapeutics" ×
  • clear all
Order by 
Showing 1 to 15 of 113
  Population-wide predictive pharmacogenomics for targeted RNA-cleaving and genome editing therapeutics (GEdit-SEQ) (Ref: SF20/APP/MOSCHOS3)
  Dr S Moschos
Applications accepted all year round

Funding Type

PhD Type

In the last decade a sleuth of interventions based on gene therapy and oligonucleotide therapeutics have received regulatory approval, paving the way for the era of personalised and N-of-1 medicine.
  Optimisation and Preclinical Evaluation of Targeted Nanoformulations of Anti‐TNF‐α Therapeutics for the Treatment of Inflammatory Bowel Disease (IBD)
  Dr Z Ramtoola, Dr B Kirby
Applications accepted all year round

Funding Type

PhD Type

Inflammatory Bowel Disease (IBD) is a chronic inflammatory condition that affects the gastrointestinal tract (GIT) of the patient and comprises of Crohn’s disease (CD) and ulcerative colitis (UC).
  Developing new antibody-based therapeutics for neuroblastoma
  Prof A Sala
Applications accepted all year round

Funding Type

PhD Type

Metastatic neuroblastoma is a cancer of the nervous system that kills the majority of the affected children. Although there have been tremendous advances in the understanding of the molecular causes of the disease, patients are still treated with highly toxic mixtures of chemicals and radiation.
  Novel microfluidic organ on a chip technologies and artificial cells for therapeutics delivery
  Dr N Kamaly
Applications accepted all year round

Funding Type

PhD Type

Technological advances in the fields of microfluidics and tissue engineering have enabled the establishment of biomimetic lab-on-a-chip systems that resemble human biology at the cellular, tissue and organ levels.
  Toward developing next-generation therapeutics - targeting the undruggable interactome
  Dr W Houssen, Prof M Jaspars, Dr L Trembleau
Applications accepted all year round

Funding Type

PhD Type

Cyclic and modified cyclic peptides are very appealing scaffolds especially as therapeutics with several examples reach the clinic e.g.
  PhD studentship - Modifier genes and therapeutics development for Joubert syndrome
  Prof J Sayer, Prof H Cordell
Application Deadline: 22 July 2020

Funding Type

PhD Type

Number of awards. 1. Start date and duration. October 2020 for 3 years. Overview.
  Fostering development of ‘smart’, responsive therapeutics against cancer-related microRNAs.
  Dr E Bichenkova, Prof D Clarke, Dr H Aojula
Applications accepted all year round

Funding Type

PhD Type

Short functional non-coding microRNAs are implicated in many types of cancer, and thus can be used as biological targets for development of more selective and powerful anticancer therapies.
  Nucleic acid aptamers for diagnostics, therapeutics and DNA nanotechnology
  Prof J Tanner
Applications accepted all year round

Funding Type

PhD Type

Nucleic acid aptamers can be evolved to bind specifically to molecules and have particular functions in a range of applications. They are also wonderful tools as adaptors and functional units in DNA nanotechnology.
  Nanoparticle-based Therapeutics to Combat Multidrug Resistance and Biofilms in Chronic Wound Infections
  Research Group: Molecular and Nanoscale Phsyics
  Dr Z Ong, Dr J R McLaughlan
Applications accepted all year round

Funding Type

PhD Type

Chronic wound infections are a significant and fast-growing global healthcare problem compounded by the widespread occurrence of antibiotic-resistant bacteria.
  Fundamentals of the Chromatographic Separation Processes of Peptide Therapeutics
  Prof D Williams
Applications accepted all year round

Funding Type

PhD Type

Imperial College are inviting applications for a PhD position to join an exciting new Engineering and Physical Sciences Research Council (EPSRC) Prosperity Partnership between Imperial, UCL and Eli Lilly on Transforming synthetic drug manufacturing.
  MRC Integrative-Toxicology Training Partnership (ITTP) PhD Studentship Identification of molecular mechanisms of late-occurring cardiotoxicity induced by oncology therapeutics
  Dr J Gill, Dr G Richardson
Application Deadline: 10 July 2020

Funding Type

PhD Type

Number of awards. 1. Start date and duration. October 2020 for 4 years. Overview. Cardiotoxicity is a major complication of cancer chemotherapy, both an acute and frequently late-onset toxicity, occurring months/years after chemotherapy.
  A 3D in vitro microphysiological model of Ewing Sarcoma to study tumour biology and screen novel therapeutics.
  Dr O Piskareva
Application Deadline: 29 May 2020

Funding Type

PhD Type

Despite advances in available therapies, adults and children with metastatic and/or relapsed Ewing Sarcoma have a five-year survival rate of 15-30%, highlighting the need for new treatments.
  MSc by Research Programme: Development of novel therapeutics against parasitic disease
  Prof M Field
Application Deadline: 16 July 2020

Funding Type

PhD Type

This course allows you to work alongside our world renowned experts from the School of Life Sciences and gain a ’real research’ experience.
  Bioinformatics for Personalized and Precision Neoantigen Therapeutics in Cancer
  Prof T Hupp, Dr JA Alfaro
Applications accepted all year round

Funding Type

PhD Type

Despite the success of immune checkpoint inhibitors in the clinic, most cancer patients do not respond, and even among responders therapeutic resistance is a problem.
  Marie Curie Early Stage Researcher (based Almac Discovery Edinburgh as part of the ETN Targeted Anti-Cancer Therapies “TACT”)

Funding Type

PhD Type

“Chemical Biology - Development of technologies for the next generation protein-drug conjugates (PDC) with improved stability and selectivity.”.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.